SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IVAX Insider Trading -- Ignore unavailable to you. Want to Upgrade?


To: flickerful who wrote (392)1/6/1998 5:38:00 PM
From: Doug  Read Replies (1) | Respond to of 756
 
Whats your prognosis for Ivx for 98?. Was incurable during 97.



To: flickerful who wrote (392)1/12/1998 8:19:00 PM
From: 5,17,37,5,101,...  Read Replies (1) | Respond to of 756
 
Good gracious! I don't know how how much more of this gobbledee gook I can take!

The buyer of this "Gelcap" plant was quoted as saying he thought he could double sales of the trash heap. Not only does the gelcap trash heap make some sort of pill but also paint bullets or caps used in crazy freak war games. Now he wants to terminate the sale. How bad can things be at that trash heap? Why did Frosty buy it to begin with? And Frosty says he is in negotiations with another buyer! Joke! I want to vomit.
*********************************************************************

IVAX Corporation's Proposed Transaction To Sell Soft-Gel Business
Terminated

MIAMI, Jan. 12 /PRNewswire/ -- IVAX Corporation (Amex: IVX) today
announced that the previously announced transaction to sell its Golden Glades soft gelatin capsule manufacturing facility and certain additional assets to Goldstar Pharmaceuticals, Inc. has been terminated. IVAX is in negotiations with other parties for the disposition of this business. [NAME THEM!] The business includes an approximately 250,000 square foot manufacturing facility located in Miami, Florida, manufacturing equipment, and the associated rights and goodwill.
IVAX Corporation, headquartered in Miami, Florida, is a holding company with core subsidiaries engaged in the research, development, manufacture and marketing of generic and branded pharmaceuticals.

SOURCE IVAX Corporation

ONE WORD: PUKE!

Jackson